Mahim Jain Selected Research

Inflammasomes

1/2018

Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahim Jain Research Topics

Disease

2	Neurodevelopmental Disorders 01/2023 - 12/2019
2	Leukoencephalopathies 01/2020 - 01/2020
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2019 - 12/2018
1	Bone Diseases (Bone Disease) 01/2021
1	Developmental Disabilities (Developmental Disability) 01/2021
1	Undiagnosed Diseases 01/2021
1	Osteoporosis 01/2021
1	Snijders Blok-Campeau syndrome 10/2020
1	Intellectual Disability (Idiocy) 01/2020
1	sponastrime type Spondyloepimetaphyseal dysplasia 01/2019
1	Strudwick syndrome 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	type 6 Osteogenesis imperfecta 07/2018
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Primary Immunodeficiency Diseases 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2018
1	Body Weight (Weight, Body) 12/2017
1	Obesity 12/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Respiratory Insufficiency (Respiratory Failure) 10/2017
1	Refractive Errors (Refractive Error) 10/2016
1	Cataract (Cataracts) 10/2016
1	Retinal Detachment (Retinal Detachments) 10/2016
1	Strabismus (Squint) 10/2016
1	Glaucoma 10/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2016
1	Insulin Resistance 04/2016
1	Ovotesticular Disorders of Sex Development 01/2016
1	Inborn Urea Cycle Disorders 09/2014
1	Maple Syrup Urine Disease 09/2014
1	Pemphigus (Pemphigus Vulgaris) 07/2014
1	Congenital disorder of glycosylation type 1G 01/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2009
1	Craniofrontonasal dysplasia 08/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2014
2	Hormones (Hormone)IBA 12/2017 - 04/2016
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Coat Protein Complex I (COPI)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	DNA HelicasesIBA 10/2020
1	Aspartate-tRNA LigaseIBA 01/2020
1	Cell Adhesion MoleculesIBA 01/2020
1	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate ElevationIBA 01/2020
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 12/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	UDP-galactose translocatorIBA 01/2019
1	CamptothecinIBA 01/2019
1	LipidsIBA 01/2019
1	fucokinaseIBA 12/2018
1	pigment epithelium-derived factorIBA 07/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2018
1	SerpinsIBA 07/2018
1	RNA Splice SitesIBA 07/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	InflammasomesIBA 01/2018
1	glycine amidinotransferase (arginine-glycine amidinotransferase)IBA 01/2018
1	Monoclonal AntibodiesIBA 12/2017
1	gamma-Aminobutyric Acid (GABA)IBA 12/2017
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2017
1	Retinaldehyde (Retinal)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	Insulin (Novolin)FDA Link 04/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Branched-Chain Amino AcidsIBA 09/2014
1	4-phenylbutyric acid (Buphenyl)FDA Link 09/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2014
1	OligosaccharidesIBA 01/2014
1	DolicholsIBA 01/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2009
1	Ephrin-B1 (Ephrin B1)IBA 08/2008

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2014
1	Mechanical Ventilators (Ventilator) 10/2017